Welcome to our dedicated page for Innospec SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Innospec Inc. (NASDAQ: IOSP), an international specialty chemicals company. These documents offer detailed information about the company’s operations across its Performance Chemicals, Fuel Specialties and Oilfield Services segments, as well as its capital structure and governance.
Innospec’s SEC filings include periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited or reviewed financial statements, segmental data and discussions of results. Investors use these filings to examine net sales, gross profit and operating income by segment, along with notes on research and development, corporate costs and regional performance.
The company also files current reports on Form 8-K to disclose material events. Recent 8-K filings have covered the release of quarterly financial results and the declaration of semi-annual dividends on IOSP common stock. These filings identify the NASDAQ listing for Innospec’s common shares and provide details such as record and payment dates for dividends.
On Stock Titan, Innospec’s filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the key points in lengthy documents. Users can quickly see which items relate to earnings, dividend actions, segment performance or other notable events. For those interested in topics such as non-GAAP measures, net cash, or segment trends in Performance Chemicals, Fuel Specialties and Oilfield Services, the filings page offers a structured way to review the company’s regulatory disclosures.
By combining real-time access to IOSP filings with AI-generated highlights, this page helps readers navigate Innospec’s official reporting without needing to read every line of each document.
Innospec Inc. director Claudia Poccia reported an open-market sale of 119 shares of common stock at an average price of $76.5562 per share. According to the filing, these shares were sold through a broker transaction solely to cover tax withholding obligations related to the vesting of time-based restricted stock units. After this tax-related sale, Poccia beneficially owns 6,508 Innospec common shares directly.
Innospec Inc. senior vice president of human resources Hardy Louis Griffin III reported a small insider transaction related to equity compensation. On vesting of a restricted stock unit award, 401 shares of common stock were automatically withheld at $78.34 per share to cover income tax obligations, rather than being an open‑market trade. After this tax-withholding disposition, Griffin directly owned 10,161 common shares, reflecting his remaining equity stake in the company.
Innospec Inc. director David Landless reported an open-market sale of 594 shares of Innospec common stock at an average price of $76.5562 per share on February 27, 2026. After this transaction, he directly holds 7,632 shares of the company’s common stock.
Innospec Inc. senior vice president, general counsel and chief compliance officer David B. Jones reported two stock transactions. He sold 1,028 shares of common stock in an open-market sale at $75.64 per share and had 875 shares withheld to cover taxes upon vesting of restricted stock units. After these transactions, he directly owned 14,693 shares of Innospec common stock.
Innospec Inc. SVP Corbin Barnes reported a tax-related share disposition. On February 27, 2026, 166 shares of common stock were withheld at $78.34 per share to cover income taxes due upon vesting of a restricted stock unit award. After this tax-withholding transaction, Barnes directly held 13,079.6117 Innospec common shares.
Innospec Inc. executive vice president and CFO Ian Cleminson reported an open-market sale of 2,380 shares of common stock at a price of $76.56 per share. After this transaction, he directly holds 20,357 shares of Innospec common stock.
Innospec Inc. President & CEO Patrick Williams reported a tax-related share disposition. On February 27, 2026, 7,966 shares of common stock were withheld at $78.34 per share to settle income tax owed on a restricted stock unit vesting, leaving him with 231,535 shares held directly.
BARNES CORBIN reported acquisition or exercise transactions in this Form 4 filing.
Innospec Inc.'s Senior Vice President of Corporate Development and Investor Relations, Corbin Barnes, received an equity award in the form of restricted stock units. The grant covers 2,481 RSUs of common stock at no cash cost and vests in full on February 23, 2029.
Following this award, Barnes now directly holds a total of 13,245.6117 shares of Innospec common stock, aligning his compensation more closely with the company’s long-term share performance.
INNOSPEC INC. senior vice president of human resources Hardy Louis Griffin III reported an equity award under the company’s compensation program. On February 23, 2026, he acquired 2,521 shares of common stock in the form of restricted stock units granted at no cash cost, which will vest in full on February 23, 2029. Following this grant, his directly owned common stock holdings total 10,562 shares.
Cleminson Ian reported acquisition or exercise transactions in this Form 4 filing.
Innospec Inc. reported that Executive Vice President and Chief Financial Officer Ian Cleminson received a grant of 4,499 shares of common stock in the form of restricted stock units. These RSUs were granted on February 23, 2026 and will vest in full on February 23, 2029. After this award, Cleminson directly holds 22,737 shares of Innospec common stock.